SCHEMBL20174232

SCHEMBL20174232

c1ccc(-c2ccc(-c3cc(-c4ccccc4-c4cccc5c4-c4oc6ccccc6c4C54c5ccccc5-c5ccccc54)cc(-c4ccccc4)n3)cc2)cc1

nearest known ligand 0.33

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
PDK2 Q15119 1/20 0.33
ADORA3 P0DMS8 1/20 0.32
KMT2A Q03164 2/20 0.31
L3MBTL1 Q9Y468 2/20 0.31
MAPK1 P28482 1/20 0.31
PLA2G2A P14555 2/20 0.31
PLA2G4A P47712 2/20 0.31
KDM4E B2RXH2 1/20 0.31
MEN1 O00255 1/20 0.31
ALDH1A1 P00352 1/20 0.31
CYP3A4 P08684 1/20 0.31
CYP2D6 P10635 1/20 0.31
MAPT P10636 1/20 0.31
CYP2C9 P11712 1/20 0.31
HPGD P15428 1/20 0.31
CYP2C19 P33261 1/20 0.31
HSD17B10 Q99714 1/20 0.31
ALOX5 P09917 1/20 0.31
DHODH Q02127 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20174247 0.93 ADORA3 (0.34) PDK2ADORA3KMT2AL3MBTL1MAPK1
SCHEMBL20174212 0.89 KMT2A (0.33) PDK2KMT2AL3MBTL1MAPK1PLA2G2A
SCHEMBL22326549 0.89 PLA2G2A (0.31) ADORA3KMT2AMAPK1PLA2G2APLA2G4A
SCHEMBL20174275 0.88 KMT2A (0.32) KMT2AMAPK1PLA2G2APLA2G4AKDM4E
SCHEMBL20174263 0.87 KMT2A (0.36) ADORA3KMT2AL3MBTL1MAPK1PLA2G2A
SCHEMBL20174301 0.87 ACACA (0.38) L3MBTL1MAPK1KDM4EALDH1A1CYP3A4
SCHEMBL22326539 0.86 CYP1A1 (0.36) KMT2AMAPK1ALDH1A1MAPT
SCHEMBL22326546 0.85 PDK2 (0.33) PDK2PLA2G2APLA2G4A
SCHEMBL20174284 0.85 PDK2 (0.39) PDK2ADORA3KMT2AMAPK1PLA2G2A
SCHEMBL20174237 0.85 PLA2G2A (0.32) ADORA3KMT2AL3MBTL1MAPK1PLA2G2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10738034-B2 Spiro compound and organic light-emitting device comprising same LG CHEM, LTD. (KR) 2020-08-11 US disclosed
US-20180141933-A1 SPIRO COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME LG CHEM, LTD. (KR) 2018-05-24 US disclosed
US-20180141933-A1 SPIRO COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME LG CHEM, LTD. (KR) 2018-05-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10738034-B2 Spiro compound and organic light-emitting device comprising same CRY1, NR2E3, ERG PDK2 651/4885ADORA3 4030/4885KMT2A 1480/4885
US-20180141933-A1 SPIRO COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME CRY1, NR2E3, ERG PDK2 651/4885ADORA3 4030/4885KMT2A 1480/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.